Online Education

19CE100 - An Overview of the Background, Inheritance and Pathophysiology of von Willebrand Disease

The purpose of this online learning activity is to enable the learner to develop an understanding of von Willebrand disease (VWD) by examining the discovery and evolution of scientific knowledge about VWD; genetic inheritance of the bleeding disorder; production, structure, and functions of von Willebrand factor (VWF); and characteristics of the different types of VWD.

• Review the history of von Willebrand Disease (VWD), including its discovery and evolution of scientific understanding of the bleeding disorder
• Discuss the epidemiology, inheritance, and diagnosis of VWD
• Examine the production, structure, and functions of von Willebrand factor (VWF)
• Differentiate the types and subtypes of VWD, including types 1, 2, and 3

Nurses and other healthcare professionals employed within the federally recognized U.S. hemophilia treatment center network (USHTCN) seeking training on von Willebrand disease (VWD) relating to the history and evolution of our understanding of the condition, the role of von Willebrand factor (VWF), and the differentiation of the multiple classifications of VWD.

This online learning activity provides an outline of the history, inheritance, and pathophysiology of von Willebrand Disease (VWD). It includes a description of how VWD was discovered and traces the evolution of knowledge about the bleeding disorder. It also details the genetic inheritance of VWD and the likelihood that offspring of an affected parent will be born with VWD. The activity examines the production and many functions of von Willebrand factor, described as “the Jedi knight of the bloodstream.” Finally, the activity differentiates the types of VWD on the basis of laboratory features. VWF function, VWF multimer quantity and quality, and symptoms.

• Roshni Kulkarni, MD
• Usha M. Reddy, MD
• Bruce L. Evatt, MD
• Connie H. Miller, PhD

July 19, 2019

5:00 PM Eastern, July 19, 2021

The estimated time to complete this activity is 45 minutes. In order to receive contact hours, you must complete the following prior to the course expiration date:

• Read the Program Announcement Form.
• Complete the learning activity.
• Complete the evaluation.
• Complete the post-test with a score of 70% or better.
• Upon successful completion of the post-test (defined as a cumulative score of at least 70% correct) your certificate of completion will be available to print or save.

The University of Nebraska Medical Center College of Nursing Continuing Nursing Education is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

This activity is provided for 0.75 contact hours under ANCC criteria.

---

This activity has been reviewed by the AAPA Review Panel and is compliant with AAPA CME Criteria. This activity is designated for 0.75 AAPA Category 1 CME credits. Approval is valid from 7/19/2020 to 7/19/2021. PAs should only claim credit commensurate with the extent of their participation. AAPA reference number: CME-200644.

Contact Information

If you have any questions about this activity, please contact Natalie Duncan in Indianapolis, IN, 317-871-0011 ext 273, toll-free 877-256-8837, or via email at nduncan@ihtc.org. For technical support please email support@partnersprn.org or open a ticket in the Partners Support Center.

System Requirements

• 2 gigabytes of RAM
• High speed internet connection
• Any one Internet browser:
  • Firefox (Most Current Version)
  • Safari (Most Current Version)
  • Google Chrome (Most Current Version)
  • MS Internet Explorer (Most Current Version)
  • Cookies and JavaScript must be enabled in all browsers.
  • All browsers must have flash plug in installed and enabled.
• Cookies and JavaScript must be enabled in all browsers.
• All browsers must have flash plug in installed and enabled.

20CE061 - Best Transition Practices for Adolescents and Young Adults with Sickle Cell Disease

The purpose of this program is to enable the learner to increase knowledge of the care needs of adolescents and young adults (AYAs), the emotional and social development of adolescence, the six core elements of a transition program, and the emotional/social milestones that should be addressed in a transition program for AYAs living with sickle cell disease (SCD).

• Review emotional and social development of adolescence
• Identify health risks associated with transition among adolescents and young adults (AYAs) living with sickle cell disease (SCD)
• Differentiate pediatric and adult models of sickle cell care
• Discuss the six core elements of a transition program
• Describe the medical, social, and educational milestones that should be addressed in a transition program for AYAs living with SCD

Nurses, nurse practitioners, physician assistants, and other health care providers who treat adolescents and young adults with sickle cell disease and wish to improve outcomes associated with the transition from pediatric to adult care for these patients.

This online learning activity is focused on improving health outcomes for adolescents and young adults (AYAs) with sickle cell disease by improving transition programs and services available for these individuals. The activity will review the emotional and social development of adolescence. It will also discuss the health risks associated with transition among AYAs living with SCD. The module differentiates the pediatric and adult models of care, and examines the six core elements of transition programs, as derived from www.GotTransition.org. Finally, the activity will address the medical, social, and educational milestones that should be addressed in transition programs for AYAs with SCD.

• Emily Riehm Meier, MD, MSHS

April 30, 2020

5:00 PM, Eastern, May 2, 2022

The estimated time to complete this activity is 30 minutes. In order to receive contact hours, you must complete the following prior to the course expiration date:

• Read the Program Announcement Form
• Complete the learning activity
• Complete the evaluation
• Complete the post-test with a score of 70% or better. Successful completion of the post-test is required to earn AAPA Category 1 CME credit. Successful completion is defined as a cumulative score of at least 70 percent correct.
• Upon successful completion of the post-test your certificate of completion will be available to print or save

The University of Nebraska Medical Center College of Nursing Continuing Nursing Education is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

This activity is provided for 0.5 contact hours under ANCC criteria.

---

This activity has been reviewed by the AAPA Review Panel and is compliant with AAPA CME Criteria. This activity is designated for 0.5 AAPA Category 1 CME credits. Approval is valid for one year from 04/30/2020. PAs should only claim credit commensurate with the extent of their participation.

Contact Information

If you have any questions about this activity, please contact Natalie Duncan in Indianapolis, IN, 317-871-0011 ext 273, toll-free 877-256-8837, or via email at nduncan@ihtc.org. For technical support please email support@partnersprn.org or open a ticket in the Partners Support Center.

System Requirements

• 2 gigabytes of RAM
• High speed internet connection
• Any one Internet browser:
  • Firefox (Most Current Version)
  • Safari (Most Current Version)
  • Google Chrome (Most Current Version)
  • MS Internet Explorer (Most Current Version)
  • Cookies and JavaScript must be enabled in all browsers.
  • All browsers must have flash plug in installed and enabled.
• Cookies and JavaScript must be enabled in all browsers.
• All browsers must have flash plug in installed and enabled.

20CE059 - Comprehensive Care of Adolescents and Young Adults with Sickle Cell Disease

The purpose of this activity is to enable the learner to gain the knowledge necessary to better manage the comprehensive care of adolescents and young adults with sickle cell disease, with the aim of improving health outcomes among these individuals.

• Interpret the screening tests needed for adolescents and young adults (AYAs) with sickle cell disease (SCD)
• Review common complications of SCD in AYAs with this condition
• Describe the contraceptive choices in girls and women with SCD
• Review management of priapism, both ischemic and stuttering, in males with SCD
• Discuss practical strategies in pain management for AYAs with SCD
• Identify disease-modifying therapies that are FDA-approved for the treatment of SCD
• Describe the primary gap in knowledge of reproductive issues for patients with SCD receiving hydroxyurea therapy

Nurses, nurse practitioners, physician assistants, and other health care providers who treat persons with sickle cell disease (SCD) and wish to improve comprehensive care services provided to adolescents and young adults (AYAs) with sickle cell disease

This online educational program covers screening tests that are important in the care of adolescents and young adults (AYAs) with sickle cell disease and the most commonly used medications in this patient group. It also covers reproductive health considerations AYAs with sickle cell disease, including the need for contraception, the existing knowledge gaps, and the epidemiology and management of priapism. Finally, the program addresses practical pain management strategies in AYAs with sickle cell disease.

• Emily Meier, MD, MSHS

May 26, 2020

5:00 PM, Eastern, May 26, 2022

The estimated time to complete this activity is 60 minutes. In order to receive contact hours, you must complete the following prior to the course expiration date:

• Read the Program Announcement Form
• Complete the learning activity
• Complete the evaluation
• Complete the post-test with a score of 70% or better. Successful completion of the post-test is required to earn AAPA Category 1 CME credit. Successful completion is defined as a cumulative score of at least 70 percent correct.
• Upon successful completion of the post-test your certificate of completion will be available to print or save

The University of Nebraska Medical Center College of Nursing Continuing Nursing Education is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.

This activity is provided for 1.0 contact hours under ANCC criteria.

This activity is provided for 0.25 contact hours related to pharmacotherapeutic content.

---

This activity has been reviewed by the AAPA Review Panel and is compliant with AAPA CME Criteria. This activity is designated for 1 AAPA Category 1 CME credits. Approval is valid from 5/26/2020 to 5/26/2022. PAs should only claim credit commensurate with the extent of their participation. AAPA reference number: CME-200437.

Contact Information

If you have any questions about this activity, please contact Natalie Duncan in Indianapolis, IN, 317-871-0011 ext 273, toll-free 877-256-8837, or via email at nduncan@ihtc.org. For technical support please email support@partnersprn.org or open a ticket in the Partners Support Center.

System Requirements

• 2 gigabytes of RAM
• High speed internet connection
• Any one Internet browser:
  • Firefox (Most Current Version)
  • Safari (Most Current Version)
  • Google Chrome (Most Current Version)
  • MS Internet Explorer (Most Current Version)
  • Cookies and JavaScript must be enabled in all browsers.
  • All browsers must have flash plug in installed and enabled.
• Cookies and JavaScript must be enabled in all browsers.
• All browsers must have flash plug in installed and enabled.

20CE060 - Hydroxyurea for the Treatment of Sickle Cell Disease

The purpose of this activity is to enable the learner to enhance his or her knowledge about the complications of sickle cell disease and the importance of hydroxyurea in reducing or preventing those complications; as well as to gain familiarity with the 2014 NHLBI guidelines concerning hydroxyurea treatment for adults living with sickle cell disease.

• Describe the most common complications of sickle cell disease, including acute chest syndrome, vaso-occlusive pain crisis, and stroke
• Discuss the rationale behind hydroxyurea as a treatment for sickle cell disease and its effectiveness at preventing sickle cell-related complications
• Analyze the mechanism of action, dosing, side effects, contraindications, and monitoring of hydroxyurea therapy for sickle cell disease
• Review the 2014 NHLBI Guidelines for hydroxyurea treatment for persons living with sickle cell disease

Nurses, nurse practitioners, physician assistants, and other health care providers who treat persons with sickle cell disease and wish to improve their knowledge of hydroxyurea as a treatment for sickle cell disease as well as hydroxyurea prescribing practices, with the aim of improving health outcomes among persons with sickle cell disease.

This online educational program reviews the most common complications of sickle cell disease and introduces the most efficacious therapy currently available to treat and prevent these complications, hydroxyurea. The authors discuss the rationale behind hydroxyurea as a therapy, its effectiveness, and national prescribing guidelines.

• Emily Riehm Meier, MD, MSHS

April 30, 2020

5:00 PM, Eastern, May 2, 2022

The estimated time to complete this activity is 45 minutes. In order to receive contact hours, you must complete the following prior to the course expiration date:

• Read the Program Announcement Form
• Complete the learning activity
• Complete the evaluation
• Complete the post-test with a score of 70% or better. Successful completion of the post-test is required to earn AAPA Category 1 CME credit. Successful completion is defined as a cumulative score of at least 70 percent correct.
• Upon successful completion of the post-test your certificate of completion will be available to print or save

The University of Nebraska Medical Center College of Nursing Continuing Nursing Education is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

This activity is provided for 0.75 contact hours under ANCC criteria.

This activity is provided for 0.3 contact hours related to pharmacotherapeutic content.

---

This activity has been reviewed by the AAPA Review Panel and is compliant with AAPA CME Criteria. This activity is designated for 0.75 AAPA Category 1 CME credits. Approval is valid for one year from 04/30/2020. PAs should only claim credit commensurate with the extent of their participation.

Contact Information

If you have any questions about this activity, please contact Natalie Duncan in Indianapolis, IN, 317-871-0011 ext 273, toll-free 877-256-8837, or via email at nduncan@ihtc.org. For technical support please email support@partnersprn.org or open a ticket in the Partners Support Center.

System Requirements

• 2 gigabytes of RAM
• High speed internet connection
• Any one Internet browser:
  • Firefox (Most Current Version)
  • Safari (Most Current Version)
  • Google Chrome (Most Current Version)
  • MS Internet Explorer (Most Current Version)
  • Cookies and JavaScript must be enabled in all browsers.
  • All browsers must have flash plug in installed and enabled.
• Cookies and JavaScript must be enabled in all browsers.
• All browsers must have flash plug in installed and enabled.